Alessandro Noseda
Director/Board Member at REGENERX BIOPHARMACEUTICALS, INC.
Net worth: - $ as of 2024-03-30
Alessandro Noseda active positions
| Companies | Position | Start | End |
|---|---|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Director/Board Member | 2019-03-31 | - |
| Independent Dir/Board Member | 2019-03-31 | - | |
Leadiant Biosciences SpA
 Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Chief Tech/Sci/R&D Officer | 2013-12-31 | - |
| Chief Executive Officer | 2006-12-31 | 2016-12-31 | |
Leadiant Biosciences, Inc.
 Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Chief Tech/Sci/R&D Officer | 2018-08-31 | - |
| Corporate Officer/Principal | 1997-12-31 | 2018-08-31 | |
| Thule Therapeutics SA | Director/Board Member | - | - |
| Rostaquo | Director/Board Member | - | - |
| Metheresis Translational Research SA | Director/Board Member | - | - |
Career history of Alessandro Noseda
Former positions of Alessandro Noseda
| Companies | Position | Start | End |
|---|---|---|---|
Leadiant Biosciences SA
 Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Chief Executive Officer | 2006-12-31 | 2016-12-31 |
Training of Alessandro Noseda
| University of Milan | Doctorate Degree |
| Wake Forest School of Medicine | Doctorate Degree |
Statistics
International
| Switzerland | 5 |
| United States | 4 |
| Italy | 3 |
Operational
| Director/Board Member | 4 |
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| REGENERX BIOPHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Leadiant Biosciences SpA
Leadiant Biosciences SpA Pharmaceuticals: MajorHealth Technology Part of Valline Srl, Leadiant Biosciences SpA develops and manufactures pharmaceutical therapies for patients with rare diseases. The company is based in Rome, Italy. The Italian company was founded in 1957. Marco Maria Brughera has been the CEO of the company since 2011. Leadiant Biosciences was acquired by CHIESI Farmaceutici SpA on October 20, 2020. | Health Technology |
Leadiant Biosciences, Inc.
Leadiant Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Leadiant Biosciences, Inc. operates as a research-based pharmaceutical company. It develops and commercializes medicines for rare diseases. The company was founded in 1989 by Claudio Cavazza and is headquartered in Gaithersburg, MD. | Health Technology |
Leadiant Biosciences SA
Leadiant Biosciences SA Miscellaneous Commercial ServicesCommercial Services Leadiant Biosciences SA conducts biotechnological research. | Commercial Services |
| Thule Therapeutics SA | |
| Rostaquo | |
| Metheresis Translational Research SA |
- Stock Market
- Insiders
- Alessandro Noseda
- Experience
